Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

Meanwhile, Litecoin led the gainers with an over 12% gain, sparking interest in large-cap and legacy altcoins.

Speculation over a spot ETF continues to build despite the SEC delaying its decision on Grayscale’s application until October ...

The August crypto market is alive with rotation. XRP investors and Litecoin holders are reallocating funds after a period of ...

As meme coin mania and DeFi rotations continue in 2025, investors are watching how early narratives evolve amid shifting ...

Dogecoin, HBAR, and Litecoin gain momentum, but Remittix (RTX) at $0.0876 is emerging as the breakout crypto to buy before ...

There is significant market optimism, with analysts assigning a 90-95% probability that the U.S. SEC will approve a spot Litecoin (LTC) ETF by October 2025. This positive outlook is primarily driven ...

In the race for the next big opportunity, crypto insiders have their sights set on a new presale that’s quickly gaining ...

Key Points MEI Pharma announced a $100 million private placement to accumulate Litecoin, as well as the addition of Charlie Lee to its board.The timing comes as Bitcoin hovers around an all-time high ...

Litecoin (LTC) is once again in the spotlight, holding near the $110 resistance level. If it breaks through $150, it could be ...

Litecoin (LTC) price has gained over 11% in the past 24 hours, reaching an intraday high of $124.90 before settling near $122 at press time.